Enliven Therapeutics Stock Analysis

Enliven Stock Analysis Notes

About 99.0% of the company shares are held by institutions such as insurance companies. The book value of Enliven Therapeutics was currently reported as 5975.16. The company recorded a loss per share of 1.89. Enliven Therapeutics had not issued any dividends in recent years. The entity had 1:4 split on the 24th of February 2023. To learn more about Enliven Therapeutics call Samuel MBA at 720 647 8519 or check out https://www.enliventherapeutics.com.

Enliven Therapeutics Investment Alerts

Enliven Therapeutics Upcoming and Recent Events

Enliven Largest EPS Surprises

View All Earnings Estimates

Enliven Therapeutics Environmental, Social, and Governance (ESG) Scores

Enliven Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.07 B.

Enliven Profitablity

Management Efficiency

Enliven Therapeutics has return on total asset (ROA) of (0.2137) % which means that it has lost $0.2137 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3098) %, meaning that it created substantial loss on money invested by shareholders. Enliven Therapeutics' management efficiency ratios could be used to measure how well Enliven Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 1st of February 2025, Return On Tangible Assets is likely to drop to -0.25. In addition to that, Return On Capital Employed is likely to drop to -0.32. At this time, Enliven Therapeutics' Total Assets are very stable compared to the past year. As of the 1st of February 2025, Other Current Assets is likely to grow to about 15.7 M, while Non Current Assets Total are likely to drop about 3.7 M.

Technical Drivers

As of the 1st of February, Enliven Therapeutics shows the Mean Deviation of 2.53, variance of 12.36, and Standard Deviation of 3.52. Enliven Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Enliven Therapeutics Price Movement Analysis

Enliven Therapeutics Insider Trading Activities

Enliven Therapeutics Outstanding Bonds

Enliven Therapeutics Predictive Daily Indicators

Enliven Therapeutics Corporate Filings

Enliven Therapeutics Forecast Models

Enliven Therapeutics' time-series forecasting models are one of many Enliven Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Enliven Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Enliven Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Enliven shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Enliven Therapeutics. By using and applying Enliven Stock analysis, traders can create a robust methodology for identifying Enliven entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Enliven analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Enliven analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Enliven Therapeutics stock analysis indicators help investors evaluate how Enliven Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Enliven Therapeutics shares will generate the highest return on investment. By understating and applying Enliven Therapeutics stock analysis, traders can identify Enliven Therapeutics position entry and exit signals to maximize returns.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enliven Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Enliven Stock, please use our How to Invest in Enliven Therapeutics guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enliven Therapeutics. If investors know Enliven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enliven Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Enliven Therapeutics is measured differently than its book value, which is the value of Enliven that is recorded on the company's balance sheet. Investors also form their own opinion of Enliven Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Enliven Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enliven Therapeutics' market value can be influenced by many factors that don't directly affect Enliven Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Enliven Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enliven Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enliven Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.